Study of GZR101-80 for type 2 diabetes
Part of Hormones & metabolism clinical trials.
This study tests an investigational medicine called GZR101-80 for people with type 2 diabetes. It aims to see how well it controls blood sugar and how safe it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have been diagnosed with type 2 diabetes for at least 6 months.
- Your body mass index (BMI) is between 18.5 and 35.0.
- You do not have type 1 diabetes or other specific types of diabetes.
- You have not had severe low blood sugar (hypoglycemia) in the last 3 months.
- You have no active cancer or history of cancer in the last 5 years (except certain skin or early-stage cancers).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injectable medication called GZR33 to help control blood sugar in people with type 2 diabetes who are already taking oral diabetes pills. The trial will measure how well it works and how safe it is.
This study tests a new injectable medicine for weight management in adults who are overweight. It aims to see how the medicine works in the body and how it affects weight.
This study tests an experimental medicine called RGB-5088 for people with type 2 diabetes who are already using insulin. The goal is to see if it can safely improve blood sugar control when added to your current diabetes management.
This trial tests a new medicine called HDM1005 for people with type 2 diabetes who haven't been helped enough by diet and exercise alone, and who haven't taken any diabetes medication in the last 12 weeks. It aims to see if the medicine can help lower blood sugar levels safely.
This trial tests a new weekly insulin called GZR4 for people with type 2 diabetes who already use basal insulin. It aims to see how well it controls blood sugar and if it is safe.
This study compares a new investigational long-acting insulin (GZR33) to an approved one (insulin degludec) in people with type 1 diabetes. You would receive both insulins during an inpatient 'clamp' procedure to see how well they work, which may help find a more affordable or convenient option for daily blood sugar control.
Hear when a new Type 2 Diabetes (T2DM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.